A 70-year-old woman with a rectal diverticulum presented with anal pendant expansion and difficulty in defecation for more than 1 year. The patient was diagnosed with a rectal diverticulum by pelvic enhanced magnetic resonance imaging (MRI), computerized tomography (CT), rectal angiography, and colonoscopy. The endoscopic diverticulum incision procedure (EDIP) was implemented with this patient. At the 4-month follow-up, anal pendant expansion and difficulty in defecation were significantly relieved. Furthermore, colonoscopy proved that there were no vestigial feces in the diverticulum.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/a-1742-4001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Symptomatic omphalomesenteric duct anomalies in children.
S Afr J Surg
October 2024
Department of Paediatric Surgery, Mehmet Akif İnan Training and Research Hospital, Turkey.
Article Synopsis
- The study focused on children with symptomatic omphalomesenteric duct (OMD) anomalies, analyzing 35 cases from a hospital over four years.
- Most patients were male (82.8%) with symptoms primarily related to gastrointestinal tract obstruction, acute abdomen, or umbilical issues.
- Surgical interventions varied, with successful outcomes and only two complications, showcasing the effectiveness of surgical treatment for these anomalies.
Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study.
Front Pharmacol
September 2024
Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
Article Synopsis
- The study aimed to analyze the safety profiles of suspected adverse events linked to rivaroxaban by utilizing data from the FDA Adverse Event Reporting System (FAERS) between 2014 and 2024.
- A total of 77,384 adverse drug reaction reports were reviewed, with 86% classified as serious; the majority of serious events occurred in individuals over 65 years old, predominantly affecting gastrointestinal and nervous system health.
- The analysis identified significant adverse effects, highlighting specific serious conditions like "Haemorrhagic arteriovenous malformation," and also noted rare but serious signals such as "Basal ganglia haematoma."
Fulminant immune-related colitis after dual checkpoint inhibitor therapy: case report.
Immunotherapy
October 2024
Department of Medicine, Division of Hematology/Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Immune-related (IR) colitis is a potentially life-threatening complication of checkpoint inhibitors. Its presentation often includes diarrhea, abdominal pain and rectal bleeding and the median time to onset is 6-10 weeks post initiation of immunotherapy. We report an unusual case of fulminant IR-colitis beginning 3 days after the first dose of dual checkpoint blockade.
View Article and Find Full Text PDFMeckel's Diverticulum Fistulating into the Rectum: An Extremely Uncommon Presentation.
Oman Med J
May 2024
Department of Pediatric Surgery and Pediatric Urology, BLK-MAX Superspeciality Hospital, New Delhi, India.
Article Synopsis
- - An 11-year-old girl experienced abdominal pain, distension, and vomiting for 20 days, along with a mass protruding from her rectum.
- - Medical examination suggested a severe intestinal blockage due to an unusual complication of Meckel's diverticulum, resembling intussusception.
- - Surgical treatment involved removing the Meckel's diverticulum that had invaded the rectum and repairing the associated injury, emphasizing the rarity of this condition.
Adverse event of the procedure for prolapsed hemorrhoids: a rare case of anastomotic diverticulum with a giant fecaloma.
Gastrointest Endosc
November 2024
Endoscopic Center, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!